MedicinesFAQ

PD-0325901

PD-0325901 Uses, Dosage, Side Effects, Food Interaction and all others data.

PD-0325901 has been used in trials studying the treatment and basic science of Melanoma, Solid Tumour, Solid Tumors, Advanced Cancer, and Breast Neoplasms, among others.

Trade Name	PD-0325901
Generic	PD-0325901
Type
Formula	C₁₆H₁₄F₃IN₂O₄
Weight	Average: 482.193 Monoisotopic: 481.995034981
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	September 19, 2023 at 7:00 am

Innovators Monograph

You find simplified version here PD-0325901

Content Sources

https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=9826528
https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=99443572
https://www.chemspider.com/Chemical-Structure.8002271.html
http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=104963
https://www.ebi.ac.uk/chebi/searchId.do?chebiId=88249
https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL507361
https://zinc.docking.org/substances/ZINC000003938683
https://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/4BM

*** Taking medicines without doctor's advice can cause long-term problems.

Download Bissoy app from Play Store to get doctor's consultation over video call